Niagen Bioscience, Inc. — Director's Dealing 2022

Oct 3, 2022

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ChromaDex Corp. (CDXC)
CIK: 0001386570
Period of Report: 2022-09-30

Reporting Person: Chau Hoi Shuen Solina Holly (10% Owner)
Reporting Person: Pioneer Step Holdings Ltd (10% Owner)
Reporting Person: Dvorak International Ltd (10% Owner)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2022-09-30	Common Stock	P	960000	$1.25	Acquired	7885641	Indirect

Footnotes

F1: Pioneer Step Holdings Limited ("Pioneer Step") has agreed to purchase 960,000 shares of the Issuer's common stock pursuant to the Securities Purchase Agreement dated September 30, 2022 by and among the Issuer, Pioneer Step and other purchasers named therein.

F2: Of the total shares beneficially owned following the reported transaction (i) 6,917,783 shares of the Issuer's common stock are directly beneficially owned by Pioneer Step, (ii) 420,000 shares of the Issuer's common stock are directly beneficially owned by Dvorak International Limited ("Dvorak International"), and (iii) 547,858 shares of the Issuer's common stock are directly beneficially owned by Skyinvest Associates Limited ("Skyinvest Associates"). Chau Hoi Shuen Solina Holly ("Solina Chau") is the sole shareholder of each of Pioneer Step, Dvorak International, and Skyinvest Associates.

F3: (continued from Footnote 2) As such, Solina Chau may be deemed to beneficially own the shares of the Issuer's common stock directly held by Pioneer Step, Dvorak International and Skyinvest Associates. Solina Chau disclaims Section 16 beneficial ownership of the securities held by each of Pioneer Step, Dvorak International and Skyinvest Associes, except to the extent of her pecuniary interest therein, if any.